MML Investors Services
CRMD icon

MML Investors Services’s CorMedix CRMD Stock Holding History

MML Investors Services’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-120,264
Closed -$1.4M – 3035
2025
Q4 		$1.4M Buy
120,264
+27,750
+30% +$307K ﹤0.01% 1595
2025
Q3 		$1.08M Buy
+92,514
New +$1.12M ﹤0.01% 1677
2024
Q1 		– Sell
-11,000
Closed -$41K – 2493
2023
Q4 		$41K Hold
11,000
– – ﹤0.01% 2424
2023
Q3 		$41K Sell
11,000
-500
-4% -$1.99K ﹤0.01% 2273
2023
Q2 		$46K Sell
11,500
-13,000
-53% -$64.3K ﹤0.01% 2274
2023
Q1 		$101K Buy
+24,500
New +$100K ﹤0.01% 1971

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

MML Investors Services's CRMD Position: Q1 2026 in Review

MML Investors Services sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 120,264 shares — an estimated $1.4M sold.

MML Investors Services first reported a position in CRMD in Q1 2023 and held it in 6 quarters. The position peaked at $1.4M in Q4 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • MML Investors Services reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • MML Investors Services sold 120,264 CorMedix shares in Q1 2026, an estimated $1.4M.
  • MML Investors Services first reported a position in CorMedix in Q1 2023 and held it in 6 quarters.
  • MML Investors Services's CorMedix position peaked at $1.4M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.